Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005129 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bogalusa Heart Study

Study acronym: BHS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Nov 2024 to Nov 2029 Start date: Jun 1972 to Aug 1973v14 Show all 2 changesShow less
    • Start date: Jun 1972 to Aug 1973
  2. Eligibility criteria expanded, about 57 wordsv13 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv12
  4. Trial status: Enrolling by Invitation to Active, Not Recruiting Enrollment target: 12000 to 11737v11 Show all 2 changesShow less
    • Enrollment target: 12000 to 11737
  5. Primary and study completion dates: Nov 2023 to Nov 2024v10
Show 8 earlier versionsHide 8 earlier versions
  1. Trial status: Active, Not Recruiting to Enrolling by Invitationv9
  2. Primary and study completion dates: Nov 2019 to Nov 2023 Publications: 626 to 654 · Study description shortened, about 1 wordv8 Show all 3 changesShow less
    • Publications: 626 to 654
    • Study description shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Study description expanded, about 16 words Publications: 475 to 626v7 Show all 2 changesShow less
    • Publications: 475 to 626

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Recruiting to Active, Not Recruiting Enrollment target: 12000 · Primary completion date: Nov 2019 · Completion date: Jul 2002 to Nov 2019 · 4 morev6 Show all 8 changesShow less
    • Enrollment target: 12000
    • Primary completion date: Nov 2019
    • Completion date: Jul 2002 to Nov 2019
    • Study description expanded, about 26 words
    • Site details revised
    • Collaborators: 2 to 4
    • Eligibility criteria expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  5. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Tulane University Trial status: Completed to Recruiting · Study sites: 0 to 1 · Collaborators expanded, about 12 wordsv5 Show all 4 changesShow less
    • Trial status: Completed to Recruiting
    • Study sites: 0 to 1
    • Collaborators expanded, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  6. Publications: 339 to 475v4 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  7. Publications: 334 to 339v3 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  8. Publications: 333 to 334v2 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
46 trials monitored
See 4 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
Hypertension
1,795 trials monitored
See 85 trials at risk
To determine the natural history of atherosclerosis, coronary artery disease, and hypertension in children and adults from birth through mid-life in a total biracial community.
Trial Details
NCT Number NCT00005129
Lead Sponsor Tulane University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS)
Conditions Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Hypertension
Enrollment 11,737 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov